Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Leflunomide Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Shop All MilliporeSigma Supelco Products
Click to view available options
Quantity:
1 g
Description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Leflunomide belongs to the new class of immunomodulating drugs with inflammatory and immunomodulating properties. It has been investigated for application in transplantation procedures. It is also an anti-rheumatic drug (DMARD) used to treat rheumatoid arthritis (RA). Its mode of action involves the inhibition of T-cell proliferation after converting to its active metabolite i.e. A771726 in humans.
Specifications
Specifications
| CAS | 75706-12-6 |
| Purity Grade Notes | These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available. |
| Physical Form | Neat |
| Linear Formula | C12H9F3N2O2 |
| MDL Number | MFCD00867593 |
| Synonym | Leflunomide; 5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide |
| Type | Certified Reference Material |
| Quantity | 1 g |
| Formula Weight | 270.21 |
| Grade | Certified Reference Material |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction